Katznelson Laurence
Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94305-5826, USA.
Pituitary. 2009;12(2):136-42. doi: 10.1007/s11102-008-0104-8.
Acromegaly is a condition characterized by growth hormone (GH) and insulin-like growth factor-1 (IGF-1) hypersecretion, and is associated with boney overgrowth, and soft tissue abnormalities due to anabolic, lipolytic, and sodium retaining actions of GH. GH and IGF-1 excess is associated with alterations in body composition, including an increase in body water and lean body mass, and a reduction in body fat. Achievement of biochemical control of the disease results in a reduction in body water and fat-free mass, and an increase in body fat. BMD is generally increased in acromegaly, though the anabolic effect of GH excess on bone is reduced, if not negated, by the presence of hypogonadism, particularly with regard to the trabecular compartment. Further studies are necessary to determine the effect of long-term biochemical control on bone density in subjects with acromegaly.
肢端肥大症是一种以生长激素(GH)和胰岛素样生长因子-1(IGF-1)分泌过多为特征的病症,与骨骼过度生长以及由于GH的合成代谢、脂肪分解和保钠作用导致的软组织异常有关。GH和IGF-1过多与身体成分改变有关,包括身体水分和瘦体重增加,以及体脂减少。实现该疾病的生化控制会导致身体水分和去脂体重减少,以及体脂增加。肢端肥大症患者的骨密度通常会增加,不过,性腺功能减退的存在,尤其是在小梁骨部分,会削弱(若不是消除的话)GH过多对骨骼的合成代谢作用。有必要开展进一步研究,以确定长期生化控制对肢端肥大症患者骨密度的影响。